Ocugen Price To Sales Ratio from 2010 to 2024

OCGN Stock  USD 0.81  0.09  12.50%   
Ocugen Price To Sales Ratio yearly trend continues to be very stable with very little volatility. Price To Sales Ratio is likely to drop to 22.11. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Ocugen's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
23.27502614
Current Value
22.11
Quarterly Volatility
4.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ocugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocugen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 582.4 K, Interest Expense of 4.2 M or Selling General Administrative of 33.6 M, as well as many indicators such as Price To Sales Ratio of 22.11, Dividend Yield of 0.0 or PTB Ratio of 3.64. Ocugen financial statements analysis is a perfect complement when working with Ocugen Valuation or Volatility modules.
  
Check out the analysis of Ocugen Correlation against competitors.

Latest Ocugen's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Ocugen Inc over the last few years. Price to Sales Ratio is figured by comparing Ocugen Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ocugen sales, a figure that is much harder to manipulate than other Ocugen Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Ocugen's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocugen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 50.47 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Ocugen Price To Sales Ratio Regression Statistics

Arithmetic Mean4,669
Geometric Mean1,621
Coefficient Of Variation96.87
Mean Deviation2,454
Median4,819
Standard Deviation4,523
Sample Variance20.5M
Range18.7K
R-Value(0.63)
Mean Square Error13.4M
R-Squared0.39
Significance0.01
Slope(633.63)
Total Sum of Squares286.4M

Ocugen Price To Sales Ratio History

2024 22.11
2023 23.28
2021 112.13
2014 4819.15
201318.7 K

About Ocugen Financial Statements

Ocugen investors utilize fundamental indicators, such as Price To Sales Ratio, to predict how Ocugen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Sales Ratio 23.28  22.11 
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:
Check out the analysis of Ocugen Correlation against competitors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.19)
Revenue Per Share
0.018
Quarterly Revenue Growth
1.353
Return On Assets
(0.48)
Return On Equity
(1.03)
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.